Logo

Insights+: COVID-19 Healthcare News Monthly Updates - October 2020

Share this

Insights+: COVID-19 Healthcare News Monthly Updates - October 2020

  • Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it
  • The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019
  • PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date

Prenetics Acquires Oxsed, Oxford University Spin-out to Scale Rapid COVID-19 Test Globally. Rapid Airport Testing has begun in Heathrow with Trials in Hong Kong International Airport.

Oct 30, 2020 | Collaboration

OncoSec Announces FDA Clearance of IND Application for Initiation of Phase 1 Clinical Trial of its CORVax12 Vaccine Candidate for COVID-19

Oct 29, 2020 | Regulatory

Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19

Oct 29, 2020 | Collaboration

Kintor Pharmaceutical's COVID-19 Clinical Trials for Proxalutamide to expand Patient Enrolment

Oct 29, 2020 | Clinical Trial

Data for Lilly's bamlanivimab (LY-CoV555) in COVID-19 outpatients published in New England Journal of Medicine

Oct 28, 2020 | Clinical Trial

Regeneron's COVID-19 Outpatient Trial Prospectively Demonstrates that REGN-COV2 Antibody Cocktail Significantly Reduced Virus Levels and Need for Further Medical Attention

Oct 28, 2020 | Clinical Trial

COVID-19 Immune Response Study Could Lead to More Effective Treatments

Oct 28, 2020 | Clinical Trial

JadiCell™ Stem Cells Licensed by Therapeutic Solutions International for Brain Injury Significantly Increased Survival of COVID-19 Patients in Double Blind FDA Clinical Trial

Oct 28, 2020 | Collaboration

Daewoong Pharmaceutical's COVID-19 Treatment Candidate Also Highly Effective against Influenza Virus

Oct 28, 2020 | Clinical Trial

Qualigen Therapeutics Receives Positive Pre-IND Response from FDA for the Clinical Development of AS1411 as a Treatment for COVID-19

Oct 28, 2020 | Regulatory

Ampio Begins Phase 1 Clinical Trial of Inhaled Ampion For COVID-19 Patients With Respiratory Distress

Oct 28, 2020 | Regulatory

Daewoong Pharmaceutical's Long-Acting Niclosamide Shows High Promise Against Upcoming COVID-19 'Twindemic'

Oct 27, 2020 | Clinical Trial

Quest Diagnostics and Catapult Health Provide Virtual Preventive Care Services for Employers During COVID-19 Pandemic and Beyond

Oct 27, 2020 | Pharma

Ampio Presents at Roth Capital Partners 2020 MedTech Innovation Forum Focusing on COVID-19 Clinical Trial Activities

Oct 26, 2020 | Clinical Trial

Clinical Study Begins for the First Oral Systemic Nitric Oxide Based Therapeutic for African Americans with COVID-19

Oct 26, 2020 | Clinical Trial

Truvian Sciences Announces Plans to Make Rapid Antibody Testing More Accessible with Easy Check COVID-19 IgM/IgG POC Antibody Test

Oct 26, 2020 | Diagnostics

Helix Receives Expanded Emergency Use Authorization for On-site Unsupervised Self-Collection and Asymptomatic Screening with the Helix® COVID-19 Test

Oct 26, 2020 | Regulatory

SQI Diagnostics Updates Clinical Progress on Novel COVID-19 Tests Under Development for U.S. FDA Regulatory Submission

Oct 26, 2020 | Regulatory

Biophytis Enrolls First Patient in Brazil in COVA, a Multinational Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patients with COVID-19 Related Respiratory Failure

Oct 26, 2020 | Clinical Trial

Entos Pharmaceuticals Awarded funding to Conduct Phase I Clinical Trial of COVID-19 DNA Vaccine

Oct 23, 2020 | Grant

FDA Approves First Treatment for COVID-19

Oct 22, 2020 | Regulatory

Arizona Based Biotech Company Finds Preliminary Success Developing an Intranasal COVID-19 Vaccine Alternative

Oct 22, 2020 | Clinical Trial

TrippBio Announces the Completion of Enrollment in a Proof of Concept Clinical Trial Evaluating the Efficacy of TD213 in Treating Patients with Confirmed COVID-19 Infections

Oct 22, 2020 | Clinical Trial

Fresenius Medical Care North America Presents New Insights Related to COVID-19 and Dialysis Innovations at Kidney Week 2020

Oct 22, 2020 | Clinical Trial

Alight and THINKMD Rapidly Adapt Established Medical Infrastructure in Fight Against COVID-19

Oct 22, 2020 | Collaboration

Kedrion's Partner, Kamada Ltd, Signs a Supply Agreement with the Israeli Health Authorities for the Investigational Anti-COVID-19 Plasma-Derived Therapy

Oct 22, 2020 | Collaboration

Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine

Oct 22, 2020 | Collaboration

COVID-19 Respiratory Monitoring with MediPines AGM100 in Long-Term Care Facilities

Oct 22, 2020 | Collaboration

Poseida Therapeutics and TScan Therapeutics Announce Research Collaboration and License Agreement to Explore Developing Allogeneic T Cell Receptor Therapies for the Treatment of COVID-19

Oct 21, 2020 | Collaboration

Facilitating the 'Vaccine Era' of COVID-19 Response: ThermoGenesis to Receive U.S. Patent for Breakthrough Serological Test Reader Technology

Oct 20, 2020 | Regulatory

OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test

Oct 20, 2020 | Launch

IncellDx to Study Maraviroc, a CCR5 antagonist, in a COVID-19 Phase 2 Clinical Trial

Oct 20, 2020 | Clinical Trial

EIB Provides Immunic With up to '24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy

Oct 20, 2020 | Grant

NHS Hospitals trial ground-breaking new decontamination technology to reduce COVID-19 transmission indoors

Oct 20, 2020 | Clinical Trial

Open Orphan/hVIVO Signs Contract with UK Government for the Development of a COVID-19 Human Challenge Study Model

Oct 20, 2020 | Collaboration

Aridis Pharmaceuticals Reports Positive Preclinical Efficacy Data of a Highly Effective Inhaled Treatment Supporting a Proposed Self-Administered Therapy for COVID-19 Patients

Oct 19, 2020 | Clinical Trial

Thermo Fisher Scientific Increases Availability of COVID-19 Testing with Sample Collection Kit from Everlywell

Oct 19, 2020 | Diagnostics

DxTerity Announces a New At-Home COVID-19 Testing Solution

Oct 19, 2020 | Diagnostics

Aetion Statement on UCSF-Led Study to Inform Drug Development for COVID-19, Future Pandemics

Oct 15, 2020 | Clinical Trial

Genalyte Obtains FDA Emergency Use Authorization for Rapid COVID-19 Antibody Test

Oct 15, 2020 | Diagnostics

Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C), a severe COVID-19 complication in Children

Oct 15, 2020 | Diagnostics

Eiger BioPharmaceuticals Announces Positive Results of Investigator Sponsored Randomized Controlled Trial at University of Toronto with Peginterferon Lambda in Outpatients with Mild to Moderate COVID-19

Oct 15, 2020 | Clinical Trial

No Aborted Fetal Material in AVM Biotechnology's COVID-19 Treatment Drug

Oct 14, 2020 | Clinical Trial

New blood test predicts which Covid-19 patients will develop severe infection

Oct 14, 2020 | Diagnostics

Novellus Therapeutics Exclusively Licenses Induced Mesenchymal Stem Cells (iMSCs) to NoveCite for COVID-19 Related Acute Respiratory Distress Syndrome (ARDS) and Other Acute Respiratory Conditions

Oct 13, 2020 | Collaboration

Medigen's COVID-19 Vaccine Combined with Dynavax's CpG 1018 Adjuvant Receives Taiwan Government Subsidy with First Participant Dosed in Early October

Oct 13, 2020 | Clinical Trial

NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100' (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to critical COVID-19

Oct 13, 2020 | Clinical Trial

University of Milan Study Finds Self-Contained, Rapid ADEXUSDx COVID-19 Antibody Test has 100% Specificity

Oct 12, 2020 | Diagnostics

Abbott Receives FDA Emergency Use Authorization for its COVID-19 IgM Antibody Blood Test

Oct 12, 2020 | Regulatory

Review Article, Authored by ZyVersa Therapeutics' Esteemed Scientific Advisors, Demonstrates the Role of Inflammasomes in the Exacerbated Immune Response Associated with COVID-19 Infection

Oct 12, 2020 | Clinical Trial

The Covid-19 pandemic is expected to further affect RhoVac's clinical phase IIb study

Oct 12, 2020 | Clinical Trial

Rigel Announces First Patients Enrolled in NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova

Oct 9, 2020 | Collaboration

Grifols anti-SARS-CoV-2 hyperimmune globulin begins clinical trial in patients with COVID-19

Oct 9, 2020 | Clinical Trial

Exogenesis Surgical Mask Reaches Primary Endpoints in COVID-19 Deactivation Challenge Trials

Oct 9, 2020 | Clinical Trial

First Patient Enrolled in NIH Phase 3 Trial to Evaluate Potential COVID-19 Hyperimmune Medicine

Oct 8, 2020 | Clinical Trial

Baricitinib has Significant Effect on Recovery Time, Most Impactful in COVID-19 Patients Requiring Oxygen

Oct 8, 2020 | Clinical Trial

Johnson & Johnson Receives European Commission Approval of Agreement to Supply 200 Million Doses of Janssen's COVID-19 Vaccine Candidate

Oct 8, 2020 | Collaboration

Prevea Health Selects Syntellis as Financial Planning Partner to Navigate COVID-19 Market Volatility

Oct 7, 2020 | Collaboration

Abbott Reports Results of ID NOW COVID-19 Interim Clinical Study from 1,003 People to Provide the Facts on Clinical Performance and to Support Public Health

Oct 7, 2020 | Clinical Trial

Centaur Biopharmaceutical Signs Expansion Agreement with Vaxart of Manufacturing for COVID-19 and Other Vaccine Candidates

Oct 7, 2020 | Collaboration

Promising Research Showing New Way To Treat And Stop The Spread Of COVID-19 Using Gene Silencing And Reactivation Of 'Innate' Immune System

Oct 6, 2020 | Clinical Trial

Karyopharm Presents Results of Selinexor at the International Society for Influenza and Other Respiratory Virus Diseases Antiviral Group Virtual Conference on Therapeutics for COVID-19

Oct 6, 2020 | Clinical Trial

CLEAR Collaborates with Quest Diagnostics to Integrate COVID-19 Test Results with 'Health Pass' for Safer Environments

Oct 5, 2020 | Collaboration

Hematogenix Unites With 19 Organizations from the Healthcare Community to Form COVID-19 Testing Industry Consortium

Oct 5, 2020 | Collaboration

Intermountain Healthcare Researchers Develop New Diagnostic Tool to Identify & Treat Patients with COVID-19 at Risk of Severe Illness, Death Due to Inflammatory Disorder

Oct 1, 2020 | Diagnostics

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions